Craig Collard - Jan 19, 2024 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Chief Executive Officer, Director
Signature
/s/ Lisa Peraza Attorney-in-fact for Craig A. Collard
Stock symbol
HRTX
Transactions as of
Jan 19, 2024
Transactions value $
$0
Form type
4
Date filed
1/19/2024, 08:58 PM
Previous filing
Nov 17, 2023
Next filing
Apr 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Employee Stock Option (Right to Buy) Award $0 +1.32M $0.00 1.32M Jan 19, 2024 Common Stock 1.32M $2.09 Direct F1
transaction HRTX Restricted Stock Units Award $0 +221K $0.00 221K Jan 19, 2024 Common Stock 221K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (01/19/2024).
F2 The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).